Literature DB >> 21763698

Structural and functional impact of cancer-related missense somatic mutations.

Zhen Shi1, John Moult.   

Abstract

A number of large-scale cancer somatic genome sequencing projects are now identifying genetic alterations in cancers. Evaluation of the effects of these mutations is essential for understanding their contribution to tumorigenesis. We have used SNPs3D, a software suite originally developed for analyzing nonsynonymous germ-line variants, to identify single-base mutations with a high impact on protein structure and function. Two machine learning methods are used: one identifying mutations that destabilize protein three-dimensional structure and the other utilizing sequence conservation and detecting all types of effects on in vivo protein function. Incorporation of detailed structure information into the analysis allows detailed interpretation of the functional effects of mutations in specific cases.  Data from a set of breast and colorectal tumors were analyzed. In known cancer genes, mutations approaching 100% of mutations are found to impact protein function, supporting the view that these methods are appropriate for identifying driver mutations. Overall, 50-60% of all somatic missense mutations are predicted to have a high impact on structural stability or to more generally affect the function of the corresponding proteins. This value is similar to the fraction of all possible missense mutations that have a high impact and is much higher than the corresponding one for human population single-nucleotide polymorphisms, at about 30%. The majority of mutations in tumor suppressors destabilize protein structure, while mutations in oncogenes operate in more varied ways, including destabilization of less active conformational states. The set of high-impact mutations encompasses the possible drivers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763698      PMCID: PMC4177034          DOI: 10.1016/j.jmb.2011.06.046

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  59 in total

1.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.

Authors:  M V Milburn; L Tong; A M deVos; A Brünger; Z Yamaizumi; S Nishimura; S H Kim
Journal:  Science       Date:  1990-02-23       Impact factor: 47.728

2.  Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins.

Authors:  L A Feig; G M Cooper
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.

Authors:  Takahide Kodama; Eiji Ikeda; Aiko Okada; Takashi Ohtsuka; Masayuki Shimoda; Takayuki Shiomi; Kazunari Yoshida; Mitsutoshi Nakada; Eiko Ohuchi; Yasunori Okada
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Humanization of an anti-p185HER2 antibody for human cancer therapy.

Authors:  P Carter; L Presta; C M Gorman; J B Ridgway; D Henner; W L Wong; A M Rowland; C Kotts; M E Carver; H M Shepard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.

Authors:  S M Franken; A J Scheidig; U Krengel; H Rensland; A Lautwein; M Geyer; K Scheffzek; R S Goody; H R Kalbitzer; E F Pai
Journal:  Biochemistry       Date:  1993-08-24       Impact factor: 3.162

7.  Human Gene Mutation Database (HGMD): 2003 update.

Authors:  Peter D Stenson; Edward V Ball; Matthew Mort; Andrew D Phillips; Jacqueline A Shiel; Nick S T Thomas; Shaun Abeysinghe; Michael Krawczak; David N Cooper
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

Review 8.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

9.  Deregulated expression of LRBA facilitates cancer cell growth.

Authors:  Jia-Wang Wang; Joshua J Gamsby; Steven L Highfill; Linda B Mora; Gregory C Bloom; Tim J Yeatman; Tien-chi Pan; Anna L Ramne; Lewis A Chodosh; W Douglas Cress; Jiandong Chen; William G Kerr
Journal:  Oncogene       Date:  2004-05-20       Impact factor: 9.867

10.  Loss of EphB6 expression in metastatic melanoma.

Authors:  Christian Hafner; Frauke Bataille; Stefanie Meyer; Bernd Becker; Alexander Roesch; Michael Landthaler; Thomas Vogt
Journal:  Int J Oncol       Date:  2003-12       Impact factor: 5.650

View more
  24 in total

1.  Genetic Basis of Common Human Disease: Insight into the Role of Missense SNPs from Genome-Wide Association Studies.

Authors:  Lipika R Pal; John Moult
Journal:  J Mol Biol       Date:  2015-05-01       Impact factor: 5.469

2.  PDB-wide identification of biological assemblies from conserved quaternary structure geometry.

Authors:  Sucharita Dey; David W Ritchie; Emmanuel D Levy
Journal:  Nat Methods       Date:  2017-11-20       Impact factor: 28.547

3.  StructMAn: annotation of single-nucleotide polymorphisms in the structural context.

Authors:  Alexander Gress; Vasily Ramensky; Joachim Büch; Andreas Keller; Olga V Kalinina
Journal:  Nucleic Acids Res       Date:  2016-05-05       Impact factor: 16.971

4.  Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers.

Authors:  Justin Ashworth; Brady Bernard; Sheila Reynolds; Christopher L Plaisier; Ilya Shmulevich; Nitin S Baliga
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

5.  Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.

Authors:  Yizhou Yin; Kunal Kundu; Lipika R Pal; John Moult
Journal:  Hum Mutat       Date:  2017-06-27       Impact factor: 4.878

6.  A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.

Authors:  Hong-Hee Won; Jong-Won Kim; Doheon Lee
Journal:  Hum Genet       Date:  2012-08-21       Impact factor: 4.132

7.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

Review 8.  Molecular mechanisms of disease-causing missense mutations.

Authors:  Shannon Stefl; Hafumi Nishi; Marharyta Petukh; Anna R Panchenko; Emil Alexov
Journal:  J Mol Biol       Date:  2013-07-16       Impact factor: 5.469

Review 9.  Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.

Authors:  Feixiong Cheng; Junfei Zhao; Zhongming Zhao
Journal:  Brief Bioinform       Date:  2015-08-24       Impact factor: 11.622

10.  An analysis of substitution, deletion and insertion mutations in cancer genes.

Authors:  Prathima Iengar
Journal:  Nucleic Acids Res       Date:  2012-04-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.